BostonGene has received numerous awards that reflect our dedication and expertise, underscoring our commitment to advancing precision medicine.


Through BostonGene, we are utilizing multiparametric discovery and big data analytics to uncover and validate biomarkers of therapeutic response.
We look forward to using BostonGene’s technology to facilitate our work in mechanisms of cancer neoantigen recognition.
Together, we are working to identify novel biomarkers and develop next-generation therapies for a true personalized approach to cancer care.
A tumor ‘‘personality’’ test: the BostonGene Tumor Portrait™ serves as a roadmap to guide treatment decision-making.